Results 251 to 260 of about 288,159 (307)

Phytochemistry, Biological Synthesis, and Pharmacology of Flavonoids from Genus <i>Polygonatum</i>. [PDF]

Molecules
Liu HQ, Qu ZY, He B, Shao C, Zhang J, Hou W.   +5 more
europepmc   +1 more source

Initial Psychometric Assessment of a Multidimensional Concept Test Addressing Ethnomedicine, Phytochemistry, and DPPH–IC50 Antioxidant Assay Analysis

Faizul Bayani, Joni Rokhmat, Aliefman Hakim, Aa Sukarso   +3 more
openalex   +2 more sources

Combining <i>in vivo</i> and <i>in vitro</i> studies to elucidate the inhibitory effect of resveratrol on vorolanib metabolism. [PDF]

Front Pharmacol
Chen D, Xia H, Cao L, Fu H, Chen Y, Jiang S, Zhan R.   +6 more
europepmc   +1 more source

MIC and IC50 for the tested microbial species using the polyphenolic extract

MIC and IC50 for the tested microbial species using the polyphenolic ...
openaire   +1 more source

Active Secondary Metabolites from Root-Associated Endophytic Fungus <i>Aspergillus tubingensis</i> ZMGR14 and Their Activities Against Plant Pathogenic Fungi. [PDF]

Biology (Basel)
Liu H, Jin H, Yang X, Xu Z, Cheng J, Wang L, Yan Z, Qin B.   +7 more
europepmc   +1 more source

Recent Developments in Ferulic Acid- and Caffeic Acid-Based Hybrids with Potential Anticancer Properties. [PDF]

Molecules
Peter S, Sibali LL, Khwaza V, Paca AM.
europepmc   +1 more source

Discovery of a novel and potent KRAS^G12V-targeting peptide with antiproliferative activity against colorectal cancer cells. [PDF]

J Enzyme Inhib Med Chem
Zhang H, Yang S, Wang Y, Niu MM, She J.
europepmc   +1 more source

<i>In vitro</i> screening of compounds for targeting gastric cancer with Y220C p53 mutation: a molecule combining zinc chelation and a Michael acceptor drives <i>CDKN1</i> and <i>BBC3</i> expression to restore a p53-dependent cytotoxicity. [PDF]

J Enzyme Inhib Med Chem
Nannini S, Sieffert C, McGown A, Gao XY, Jarvis A, Kostakis GE, Galvacsi A, Kallay C, Moraru R, Baud MG, Mandel S, Balourdas DI, Joerger AC, Orvain C, Peschard S, Nion A, Mellitzer G, Lottiaux S, Spencer J, Gross I, Gaiddon C.   +20 more
europepmc   +1 more source

The antitumor promise of furo[2,3-<i>d</i>]pyrimidine: a 2016-2025 review. [PDF]

RSC Adv
Mansour MA, Elshafei HA, Sayed AS, Ashour AA, Hussein NE, Abdel Karim MM, Kamel FM, Elsayed NT, Ahmed MR, Seleem MT, Gomaa RM.   +10 more
europepmc   +1 more source